Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$0.93 - $1.51 $801 - $1,301
-862 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$1.03 - $1.7 $57,822 - $95,434
-56,138 Reduced 98.49%
862 $1,000
Q4 2019

Feb 05, 2020

SELL
$1.66 - $2.4 $38,180 - $55,200
-23,000 Reduced 28.75%
57,000 $120,000
Q2 2019

Aug 09, 2019

BUY
$2.1 - $3.93 $168,000 - $314,400
80,000 New
80,000 $202,000

About ACELRX PHARMACEUTICALS INC


  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.